<DOC>
	<DOCNO>NCT02315651</DOCNO>
	<brief_summary>The aim study evaluate effect nutritional supplement co-enzyme Q10 ( CoQ10 ) methylphenidate-treated ADHD child randomize , double-blinded , placebo-controlled prospective study . All eligible patient undergo randomization divide 2 group : CoQ10-enriched snack placebo snack group . According power calculation , total 60 subject expect participate study . After screen eligibility ( 14 day ) , study divide three phase : pre-treatment ( first assessment ) phase ( 14 day ) , treatment phase 8 week treatment , post-treatment phase . Screening : participant undergo screen protocol eligibility within 14 day ( two week ) recruitment . Subjects meet inclusion criterion sign approve informed consent ( parent child ) enrol .</brief_summary>
	<brief_title>Efficacy Combined Treatment With CoQ10 Methylphenidate Children With Attention Deficit Hyperactivity Disorder</brief_title>
	<detailed_description>The aim study evaluate effect nutritional supplement co-enzyme Q10 ( CoQ10 ) methylphenidate-treated ADHD child randomize , double-blinded , placebo-controlled prospective study . All eligible patient undergo randomization divide 2 group : CoQ10-enriched snack placebo snack group . According power calculation , total 60 subject expect participate study . After screen eligibility ( 14 day ) , study divide three phase : pre-treatment ( first assessment ) phase ( 14 day ) , treatment phase 8 week treatment , post-treatment phase . Screening : participant undergo screen protocol eligibility within 14 day ( two week ) recruitment . Subjects meet inclusion criterion sign approve informed consent ( parent child ) enrol . Pre-treatment period ( 1-st phase ) : purpose first assessment , participant ' parent receive Conner 's questionnaire filling parent teacher . The first nutritional assessment undertaken use 24-h recall assessment . Treatment period ( 2-st phase ) : randomization treatment . After randomization 2 group , CoQ10 placebo group , participant ' parent receive either CoQ10-enriched placebo snack 8 week ( 2 month ) period . The participant parent instructed consume snack daily . During study subject manage methylphenidate treatment indicated neurologist . Post-treatment assessment ( 3-rd phase ) : At end study period , additional assessment identical pre-treatment take evaluate subject ' response snack . Statistical analysis ( 4-th phase ) : At end study , statistical analysis undertaken . Statistical difference two group pre-treatment post-treatment behavioral nutritional response serve evidence efficacy supplement use . All data document patient chart individual computerized case report form . The duration study expect 2 year .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<mesh_term>Methylphenidate</mesh_term>
	<criteria>Children age 612 . Diagnosed ADHD accord DSM4 At least 3 month treat methylphenidate Informed consent parent agreement teacher participation trial Adolescent girls 3 menses History current diagnosis systemic disease , diabetes , thyroid abnormality problem neural system , epilepsy brain tumor . Children psychiatric disorder , diagnose accord DSM4 . Children risk suicide . Using psychiatric medication methylphenidate . Using dietary supplement least 4 week enrollment . History abuse alcohol drug accord DSM4 . Consuming 250 mg caffeine . Allergy one snack 's ingredient . Use drug chronic disease</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>